Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The broader comparison of injectable vs oral peptides examines the bioavailability differences that make injection the preferred route for most peptide researchers
Will order again Very helpful Ive loved this product and the company was great with answering questions
This product is intended for laboratory research use only (in vitro)
The appeal for patients is in accelerated repair, improved functional recovery, and the potential to address injury-related limitations through biologically active compounds
Samples were tested for the presence of AIs (2-androstenol (5-androst-2-en-17-ol), 2-androstenone (5-androst-2-en-17-one), 3-androstenol (5-androst-3-en-17-ol), 3-androstenone (5-androst-3-en-17-one), 4-androstene-3,6,17 trione (6-oxo), aminoglutethimide, anastrozole, androsta-1,4,6-triene-3,17-dione (androstatrienedione), androsta-3,5-diene-7,17-dione (arimistane), exemestane, formestane, letrozole, and testolactone), and anti-estrogenic substance (bazedoxifene, clomiphene, cyclofenil, fulvestrant, ospemifene, raloxifene, tamoxifen, and toremifene) prohibited by WADA
US$ 23.21
US$ 27.22
US$ 22.00
US$ 24.83
US$ 28.65
US$ 27.73
US$ 29.23
US$ 26.41
US$ 28.55
US$ 24.42
